glp 1 cardiovascular risk reduction outcomes in major trials with GLP-1 receptor agonists GLP-1 receptor agonists as promising

Inflammatory Bowel Disease Conditions such as Crohn disease involve chronic inflammation of the digestive tract

Neuroprotective and Cognitive Research: Studies have demonstrated that GHRP-6 and ghrelin analogs exhibit neuroprotective effects by shielding neurons from oxidative and ischemic damage and enhancing cognitive function in neurodegenerative models

However, Novo Nordisk applied for Patent Term Extension, which is a mechanism that can extend the life of a patent for several years based upon delay due to a pharmaceuticals approval process at the FDA

50 years on and still very much alive: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics

Source: Rockefeller University

These findings were further confirmed by TMAO levels in urine samples (Figure S2a-b)